These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 7577659

  • 1. Management of persistent B19 parvovirus infection in AIDS.
    Ramratnam B, Gollerkeri A, Schiffman FJ, Rintels P, Flanigan TP.
    Br J Haematol; 1995 Sep; 91(1):90-2. PubMed ID: 7577659
    [Abstract] [Full Text] [Related]

  • 2. Fifth disease after immunoglobulin administration in an AIDS patient with parvovirus-induced red cell aplasia.
    French AL, Sacks L, Schechter GP.
    Am J Med; 1996 Jul; 101(1):108-9. PubMed ID: 8686703
    [No Abstract] [Full Text] [Related]

  • 3. Red cell aplasia caused by parvovirus B19 in AIDS: use of i.v. immunoglobulin.
    Koduri PR, Kumapley R, Khokha ND, Patel AR.
    Ann Hematol; 1997 Jul; 75(1-2):67-8. PubMed ID: 9322687
    [Abstract] [Full Text] [Related]

  • 4. Parvovirus B19-induced persistent pure red cell aplasia in a child with T-cell immunodeficiency.
    Tavil B, Sanal O, Turul T, Yel L, Gurgey A, Gumruk F.
    Pediatr Hematol Oncol; 2009 Mar; 26(2):63-8. PubMed ID: 19322736
    [Abstract] [Full Text] [Related]

  • 5. Parvovirus B19-related anemia in HIV-infected patients.
    Koduri PR.
    AIDS Patient Care STDS; 2000 Jan; 14(1):7-11. PubMed ID: 12240888
    [Abstract] [Full Text] [Related]

  • 6. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.
    Koduri PR, Kumapley R, Valladares J, Teter C.
    Am J Hematol; 1999 May; 61(1):16-20. PubMed ID: 10331506
    [Abstract] [Full Text] [Related]

  • 7. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM, Flynn JT, Schechner RS, Pullman JM, Feuerstein D, Del Rio M.
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [Abstract] [Full Text] [Related]

  • 8. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin.
    Ramage JK, Hale A, Gane E, Cohen B, Boyle M, Mufti G, Williams R.
    Lancet; 1994 Mar 12; 343(8898):667-8. PubMed ID: 7906821
    [No Abstract] [Full Text] [Related]

  • 9. Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation.
    Koda Y, Mori T, Kato J, Kohashi S, Kikuchi T, Mitsuhashi T, Murata M, Uemura T, Handa M, Okamoto S.
    Transpl Infect Dis; 2013 Dec 12; 15(6):E239-42. PubMed ID: 24134728
    [Abstract] [Full Text] [Related]

  • 10. Isolated Anemia in a 69-Year-Old Man with HIV-1: Features of Pure Red Cell Aplasia Mediated by Chronic Parvovirus-B19 Infection.
    Wylde J, Berneri MA, Malherbe JAJ, Davel S.
    Am J Case Rep; 2022 Jul 25; 23():e936445. PubMed ID: 35871772
    [Abstract] [Full Text] [Related]

  • 11. [Parvovirus B19 infection in HIV-infected patients].
    Petrenko AA, Dudina GA, Kremneva NV, Pivnik AV.
    Ter Arkh; 2020 Sep 01; 92(7):100-103. PubMed ID: 33346452
    [Abstract] [Full Text] [Related]

  • 12. Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy.
    Mylonakis E, Dickinson BP, Mileno MD, Flanigan T, Schiffman FJ, Mega A, Rich JD.
    Am J Hematol; 1999 Feb 01; 60(2):164-6. PubMed ID: 9929113
    [Abstract] [Full Text] [Related]

  • 13. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
    Ahsan N, Holman MJ, Gocke CD, Groff JA, Yang HC.
    Clin Transplant; 1997 Aug 01; 11(4):265-70. PubMed ID: 9267713
    [Abstract] [Full Text] [Related]

  • 14. Parvovirus-B19-associated complications in renal transplant recipients.
    Waldman M, Kopp JB.
    Nat Clin Pract Nephrol; 2007 Oct 01; 3(10):540-50. PubMed ID: 17895931
    [Abstract] [Full Text] [Related]

  • 15. Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection.
    Gottlieb F, Deutsch J.
    Am J Med; 1992 Mar 01; 92(3):331-3. PubMed ID: 1546732
    [Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
    Mouthon L, Guillevin L, Tellier Z.
    Autoimmun Rev; 2005 Jun 01; 4(5):264-9. PubMed ID: 15990072
    [Abstract] [Full Text] [Related]

  • 17. Parvovirus infection and its treatment.
    Young NS.
    Clin Exp Immunol; 1996 May 01; 104 Suppl 1():26-30. PubMed ID: 8625539
    [Abstract] [Full Text] [Related]

  • 18. Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection.
    Rivas-Delgado A, Matutes E, Rozman M.
    Br J Haematol; 2016 Feb 01; 172(4):495. PubMed ID: 26457576
    [No Abstract] [Full Text] [Related]

  • 19. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.
    Tiong M, Casan J, McLean C.
    Transpl Infect Dis; 2019 Apr 01; 21(2):e13045. PubMed ID: 30586222
    [Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
    Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, Montagnier-Petrissans C, Guillevin L, Mouthon L, Groupe d'experts de l'Assistance Publique-Hôpitaux de Paris.
    Clin Infect Dis; 2013 Apr 01; 56(7):968-77. PubMed ID: 23243178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.